Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO): A Multicenter, Prospective, Randomized Controlled, Open-label, Blinded-Endpoint Clinical Trial

NCT07469293 is registered in ClinicalTrials.gov with Southwest Hospital, China as lead sponsor.

NCT NCT07469293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07469293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO): A Multicenter, Prospective, Randomized Controlled, Open-label, Blinded-Endpoint Clinical Trial
Lead sponsor
Southwest Hospital, China
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 25, 2026
Completion date
December 31, 2028
Enrollment
488 (estimated)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke